Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene

scientific article published on 23 May 2007

Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene is …
instance of (P31):
scholarly articleQ13442814

External links are
P932PMC publication ID2768759
P698PubMed publication ID17563725

P2093author name stringUday B Kompella
Harriet Davidson
Dolores Takemoto
Micheal E Barnett
Yun Mo
P2860cites workExpression of superoxide dismutase in whole lens prevents cataract formationQ24293031
Synthetic DNA delivery systemsQ28142096
Evidence for the role of alveolar epithelial gp60 in active transalveolar albumin transport in the rat lungQ28366239
Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degenerationQ28590177
Nuclear protein import in permeabilized mammalian cells requires soluble cytoplasmic factorsQ29620194
Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles.Q33202530
The role of oxidative stress in the pathogenesis of age-related macular degeneration.Q34060719
Nonviral gene therapy and its delivery systemsQ34324591
Albondin-mediated capillary permeability to albumin. Differential role of receptors in endothelial transcytosis and endocytosis of native and modified albuminsQ34336609
Practical aspects of the ligand-binding and enzymatic properties of human serum albumin.Q34702948
Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degenerationQ35084405
The retina: oxidative stress and diabetesQ35576292
Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequencesQ35677091
Age-related nuclear cataract-oxidation is the key.Q36111043
Periocular routes for retinal drug deliveryQ36316631
Oxygen and retinopathy of prematurityQ36398131
Uptake pathways and subsequent intracellular trafficking in nonviral gene deliveryQ36409586
Structure and ligand binding properties of human serum albuminQ37873920
Polypropylenimine dendrimer-induced gene expression changes: the effect of complexation with DNA, dendrimer generation and cell type.Q38519496
Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acidsQ40391286
Serum albumin enhances polyethylenimine-mediated gene delivery to human respiratory epithelial cellsQ40395997
Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cellsQ40404364
Transfection efficiency and uptake process of polyplexes in human lung endothelial cells: a comparative study in non-polarized and polarized cells.Q40448238
Local and systemic inhibition of lung tumor growth after nanoparticle-mediated mda-7/IL-24 gene delivery.Q40463212
Synthesis of biodegradable multi-block copolymers of poly(L-lysine) and poly(ethylene glycol) as a non-viral gene carrierQ40542430
Albumin nanoparticles improved the stability, nuclear accumulation and anticytomegaloviral activity of a phosphodiester oligonucleotide.Q40606065
Human serum albumin-polyethylenimine nanoparticles for gene deliveryQ40633583
Folate receptor mediated DNA delivery into tumor cells: potosomal disruption results in enhanced gene expressionQ41035885
High affinity binding, endocytosis, and degradation of conformationally modified albumins. Potential role of gp30 and gp18 as novel scavenger receptors.Q41560398
Endocytosis of formaldehyde-treated serum albumin via scavenger pathway in liver endothelial cellsQ42867898
Chitosan microparticles containing plasmid DNA as potential oral gene delivery systemQ46781091
In vivo passage of albumin from the aqueous humor into the lens.Q47791826
Sustained release of PEG-g-chitosan complexed DNA from poly(lactide-co-glycolide).Q51300154
Protein composition of human aqueous humor: SDS-PAGE analysis of surgical and post-mortem samples.Q51758042
Albumin nanoparticles as carriers for a phosphodiester oligonucleotideQ74693408
Oxidative stress in Adamantiades-Behçet's diseaseQ77748260
Nanoparticles sustain expression of Flt intraceptors in the cornea and inhibit injury-induced corneal angiogenesisQ80219462
Lipid transfer between cationic vesicles and lipid-DNA lipoplexes: effect of serumQ80349323
P921main subjectnanoparticleQ61231
P304page(s)746-757
P577publication date2007-05-23
P1433published inMolecular VisionQ6895981
P1476titleHuman serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene
P478volume13

Reverse relations

cites work (P2860)
Q37786424Applications of nanoparticles in ophthalmology
Q55024462Bio-Inspired Protein-Based Nanoformulations for Cancer Theranostics.
Q37676230Correction of Monogenic and Common Retinal Disorders with Gene Therapy
Q61811208Drug Exchange between Albumin Nanoparticles and Erythrocyte Membranes
Q30478379Drug delivery to the posterior segment of the eye for pharmacologic therapy
Q30459643Gene therapy in the cornea: 2005--present
Q37399016Influence of dosage form on the intravitreal pharmacokinetics of diclofenac
Q41442716Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV.
Q33380235Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina
Q42273522Mitotic and antiapoptotic effects of nanoparticles coencapsulating human VEGF and human angiopoietin-1 on vascular endothelial cells
Q37241328Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice
Q38282885Nanocarriers of nanotechnology in retinal diseases
Q38100561Nanomedicines for back of the eye drug delivery, gene delivery, and imaging
Q35843512Nanoparticle-based technologies for retinal gene therapy
Q36396201Nanoparticle-motivated gene delivery for ophthalmic application
Q38119238Nanoparticles in the ocular drug delivery
Q36425890Non-viral therapeutic approaches to ocular diseases: An overview and future directions
Q62002029Nucleus-Targeted Organoiridium-Albumin Conjugate for Photodynamic Cancer Therapy
Q38063860Ocular Drug Delivery; Impact of in vitro Cell Culture Models
Q92140652Resveratrol loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles for tail vein injection II: pharmacokinetics, tissue distribution and bioavailability
Q37415842Surface-functionalized nanoparticles for targeted gene delivery across nasal respiratory epithelium